Oruka Therapeutics, Inc. ORKA Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Oruka Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s return on equity?
- Oruka Therapeutics, Inc. (ORKA) reported return on equity of -27.3% in Q1 2026.
- How has Oruka Therapeutics, Inc.'s return on equity changed year-over-year?
- Oruka Therapeutics, Inc.'s return on equity increased by 68.0% year-over-year, from -85.3% to -27.3%.
- What is the long-term trend for Oruka Therapeutics, Inc.'s return on equity?
- Over 5 years (2020 to 2025), Oruka Therapeutics, Inc.'s return on equity has grown at a -7.3% compound annual growth rate (CAGR), from -36% to -24.7%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.